Sabra Health Care REIT, Inc. announced that it has amended and restated its credit facility, improving its debt maturity profile while keeping capacity and pricing consistent with its prior credit facility. Summary: $1.0 billion unsecured revolving credit facility maturing in January 2027, with two additional six-month extension options; USD 430 million unsecured term loan maturing in January 2028; CAD 150 million (USD 110 million) unsecured term loan maturing in January 2028; Pricing is consistent with the prior credit facility and will be based on adjusted SOFR/CDOR plus a spread of 77.5-145 bps for the revolver, and 85-165 bps for the term loans. At closing, the spread for Sabra's borrowings under the revolver and term loans were 110 bps and 125 bps, respectively; Additionally, an accordion feature affords Sabra the optionality to seek an increase in the capacity of the credit facility to $2.75 billion, subject to customary terms and conditions.